Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500198 · ClinicalTrials.gov registry record · NA
Clinical Investigation of the Next Generation Intraocular Lens
A NA study, sponsored by Johnson & Johnson Surgical Vision.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
NCT03500198 is a NA study that has completed, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 247 participants.
The verdict
NCT03500198, a NA study, has completed, sponsored by Johnson & Johnson Surgical Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
Study Summary
An investigational IOL designed to provide improved intermediate and near visual acuity and decreased spectacle wear was evaluated for safety and effectiveness in a six-month study.
Interventions
- DEVICE Investigational Intraocular Lens Device #1: Next Generation TECNIS IOL
- DEVICE Control Monofocal Intraocular Lens: TECNIS Monofocal IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2019-06-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500198
The ClinicalTrials.gov registry entry for NCT03500198 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Surgical Vision, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Investigational Intraocular Lens Device #1: Next Generation TECNIS IOL is the first listed.
NCT03500198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500198 about?
NCT03500198 is a clinical study titled "Clinical Investigation of the Next Generation Intraocular Lens". An investigational IOL designed to provide improved intermediate and near visual acuity and decreased spectacle wear was evaluated for safety and effectiveness in a six-month study.
What is the current status of trial NCT03500198?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2018-06-28. Estimated completion is 2019-06-05.
What interventions are being tested in trial NCT03500198?
The interventions under investigation include: Investigational Intraocular Lens Device #1: Next Generation TECNIS IOL (DEVICE), Control Monofocal Intraocular Lens: TECNIS Monofocal IOL (DEVICE).
Who is sponsoring clinical trial NCT03500198?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.